Women in Health: Vaccine safety Prof on her passion for making a difference

During the height of the COVID-19 pandemic, many committees and organisations were working around the clock to prepare the country for the rollout of COVID-19 vaccines. Professor Hannelie Meyer, a pharmacist-turned-academic and later vaccine advocate, served on several of these committees. Elri Voigt spoke to Meyer about the pandemic, the mottos that guide her, and being an unapologetic workaholic.

Read More

Opinion: An interdict on teen vaccination will harm basic education and violate the rights of learners

The African Christian Democratic Party and partners are in the High Court today and tomorrow seeking to stop the rollout of COVID-19 vaccines to adolescents. But in a context where the majority of learners attend schools with infrastructure problems and serious overcrowding, vaccines remain a critical tool to keep learners safe and prevent outbreaks of infection at schools, argue Julia Chaskalson and Zeenat Sujee.

Read More

COVID-19: How to respond to vaccine hesitancy

Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.

Read More

COVID-19: What is behind the low vaccination numbers in Khayelitsha and Mitchell’s Plain?

The Western Cape Department of Health has identified Khayelitsha and Mitchell’s Plain as the areas with the lowest vaccinations and vaccine registrations in the Cape Town metro. By Monday 30 August, only 22.37% of Mitchell’s Plain’s vaccine-eligible population older than 18 years have registered. In Khayelitsha, this number stood at 12.05%. Siyabonga Kamnqa visited the two areas to find out more.

Read More

COVID-19: Local researchers welcome Sputnik V vaccine findings

Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.

Read More